Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Therapeutics Announces Placement And Fully Underwritten 1 For 4 Entitlement Offer

Nov 8 (Reuters) - Amplia Therapeutics Ltd  ATX.AX :
    * PLACEMENT AND FULLY UNDERWRITTEN 1 FOR 4 ENTITLEMENT OFFER
TO
RAISE A$12.4 MILLION
    * POISED TO INITIATE A PHASE 2 CLINICAL TRIAL OF ITS FAK
INHIBITOR
AMP945 IN PATIENTS WITH PANCREATIC CANCER
    * PLACEMENT AT OFFER PRICE OF A$0.18 PER NEW SHARE

Source text for Eikon:  ID:nASX5nBnkj 
Further company coverage:  ATX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news